Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action

Journal of the Neurological Sciences

Volumn 322, Issue 1-2, 2012, Pages 222-227

  MacHicao, Fausto ^a   Muresanu, Dafin Fior ^b   Hundsberger, Harald ^c   Pflüger, Maren ^c   Guekht, Alla ^d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c IMC UNIVERSITY OF APPLIED SCIENCES KREMS   (Austria)

^d PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Actovegin; Apoptosis; Metabolic effects; Mode of action; Neuroprotection; Oxidative stress

Indexed keywords

ACTOVEGIN; AMYLOID BETA PROTEIN[25-35]; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

AEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; GLUCOSE TRANSPORT; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; METABOLIC BALANCE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HEME; HUMANS; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84867577337     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.07.069     Document Type: Article

References (56)

1. D.F. Muresanu Neuromodulation with pleiotropic and multimodal drugs - future approaches to treatment of neurological disorders Acta Neurochir Suppl 106 2010 291 294
2. L.A. Labiche, and J.C. Grotta Clinical trials for cytoprotection in stroke NeuroRx 1 1 Jan. 2004 46 70
3. A.I. Maas, B. Roozenbeek, and G.T. Manley Clinical trials in traumatic brain injury: past experience and current developments Neurotherapeutics 7 1 2010 Jan 115 126
4. N.M. Bornstein Stroke: practical guide for physicians 2009 S. Karger AG
5. D.F. Muresanu Neuroprotection and neuroplasticity - a holistic approach and future perspectives J Neurol Sci 257 1-2 2007 Jun 15 38 43
6. H. Mochida, T. Kikuchi, H. Tanaka, A. Ikeda, Y. Fujii, and T. Sasamura Influence of Actovegin containing infusion solutions on wound healing and function of the intestinal tract in rats Pharmacol Ther 17 1989 789 797
7. D. Schonwald, B. Sixt, F. Machicao, E. Marx, G. Haedenkamp, and S. Bertsch Enhanced proliferation of coronary endothelial cells in response to growth factors is synergized by hemodialysate compounds in vitro Res Exp Med (Berl) 191 4 1991 259 272
8. S.K. Basu, M.N. Srinivasan, K. Chuttani, and A. Ghose Evaluation of some radioprotectors by the survival study of rats exposed to lethal dose of whole body gamma radiation J Radiat Res (Tokyo) 26 4 1985 Dec 395 403
9. N. Hegner Wirkung eines deproteinisierten Hämoderivates (Actovegin) im induzierten hypovolämischen Schock unter besonderen Berü cksichtigung des Energiestoffwechsels 1983 Institut für Anästhesiologie Johannes-Gutenberg Universität Mainz
10. P. Giarola Effects of blood extract on plasma lipids, blood coagulation, fibrinolysis, and platelet aggregation in experimental hypercholesterolemia of rabbits Arzneim-Forsch 24 1974 925 928
11. M.W. Elmlinger, M. Kriebel, and D. Ziegler Neuroprotective and anti-oxidative effects of the hemodialysate actovegin on primary rat neurons in vitro Neuromolecular Med 13 4 2011 Dec 266 274
12. A. Dieckmann, M. Kriebel, E. Andriambeloson, D. Ziegler, and M. Elmlinger Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation Exp Clin Endocrinol Diabetes 120 3 2011 Oct 21 132 138
13. T. Kuninaka, Y. Senga, H. Senga, and M. Weiner Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract J Cell Physiol 146 1 1991 Jan 148 155
14. F. Buchmayer, J. Pleiner, M.W. Elmlinger, G. Lauer, G. Nell, and H.H. Sitte Actovegin®: a biological drug for more than 5 decades Wien Med Wochenschr 161 3-4 2011 Feb 80 88
15. W. Bachmann, H. Forster, and H. Mehnert Experimental studies in animals on the effect of a protein-free blood extract on the metabolism of glucose Arzneim-Forsch 18 1968 1023 1027
16. J. Rao, G. Oz, and E.R. Seaquist Regulation of cerebral glucose metabolism Minerva Endocrinol 31 2 2006 Jun 149 158
17. B.S. McEwen, and L.P. Reagan Glucose transporter expression in the central nervous system: relationship to synaptic function Eur J Pharmacol 490 1-3 2004 Apr 19 13 24
18. C.A. Grillo, G.G. Piroli, R.M. Hendry, and L.P. Reagan Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent Brain Res 1296 2009 Nov 3 35 45
19. M. Kobayashi, H. Nikami, M. Morimatsu, and M. Saito Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain Neurosci Lett 213 2 1996 Aug 2 103 106
20. W.M. Pardridge, W.H. Oldendorf, P. Cancilla, and H.J. Frank Blood-brain barrier: interface between internal medicine and the brain Ann Intern Med 105 1 1986 Jul 82 95
21. W.Q. Zhao, H. Chen, M.J. Quon, and D.L. Alkon Insulin and the insulin receptor in experimental models of learning and memory Eur J Pharmacol 490 1-3 2004 Apr 19 71 81
22. R. Nitsch, and S. Hoyer Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex Neurosci Lett 128 2 1991 Jul 22 199 202
23. A. Ding, G. Nemeth, and S. Hoyer Age influences abnormalities in striatal dopamine metabolism during and after transient forebrain ischemia J Neural Transm Park Dis Dement Sect 4 3 1992 213 225
24. H. Lannert, and S. Hoyer Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats Behav Neurosci 112 5 1998 Oct 1199 1208
25. M. Salkovic-Petrisic, and S. Hoyer Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach J Neural Transm Suppl 72 2007 217 233
26. F. Machicao, C. Mühlbacher, and H. Haring Inositol phospho-oligosaccharides from a dialysate (Actovegin) obtained from blood mimic the effect of lipogenesis glucose transport and lipolysis in rat adipocytes Akt Endokr Stoffw 10 1989 111
27. M. Kellerer, F. Machicao, L. Berti, B. Sixt, J. Mushack, and E. Seffer Inositol phospho-oligosaccharides from rat fibroblasts and adipocytes stimulate 3-O-methylglucose transport Biochem J 295 Pt 3 1993 Nov 1 699 704
28. H. Reichel, C. Weiss, and H.P. Leichtweiss The effects of a blood extract on the oxygen uptake of isolated artificially perfused kidneys and skeletal muscles in rats Arzneim-Forsch 15 756 1965 757
29. H. de Groot, M. Brecht, and F. Machicao Evidence for a factor protective against hypoxic liver parenchymal cell injury in a protein-free blood extract Res Commun Chem Pathol Pharmacol 68 1 Apr. 1990 125 128
30. S. Hoyer, and K. Betz Elimination of the delayed postischemic energy deficit in cerebral cortex and hippocampus of aged rats with a dried, deproteinized blood extract (Actovegin) Arch Gerontol Geriatr 9 2 1989 Sep 181 192
31. K. Murakami, T. Shimizu, and K. Irie Formation of the 42-mer amyloid beta radical and the therapeutic role of superoxide dismutase in Alzheimer's disease J. Amino Acids 2011 2011 654207
32. X.H. Zhang, H.L. Yu, R. Xiao, L. Xiang, L. Li, and W.W. Ma Neurotoxicity of beta-amyloid peptide 31-35 and 25-35 to cultured rat cortical neurons Zhonghua Yu Fang Yi Xue Za Zhi 43 12 2009 Dec 1081 1085
33. C.J. Pike, A.J. Walencewicz-Wasserman, J. Kosmoski, D.H. Cribbs, C.G. Glabe, and C.W. Cotman Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity J Neurochem 64 1 1995 Jan 253 265
34. L. Millucci, R. Raggiaschi, D. Franceschini, G. Terstappen, and A. Santucci Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide J Biosci 34 2 2009 Jun 293 303
35. V.V. Trubetskaya, M.Y. Stepanichev, M.V. Onufriev, N.A. Lazareva, V.A. Markevich, and N.V. Gulyaeva Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo Neurosci Behav Physiol 33 2 2003 Feb 95 98
36. B. Klementiev, T. Novikova, V. Novitskaya, P.S. Walmod, O. Dmytriyeva, and B. Pakkenberg A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35 Neuroscience 145 1 2007 Mar 2 209 224
37. T. Kubo, S. Nishimura, Y. Kumagae, and I. Kaneko In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients J Neurosci Res 70 3 2002 Nov 1 474 483
38. M.K. Meffert, J.M. Chang, B.J. Wiltgen, M.S. Fanselow, and D. Baltimore NF-kappa B functions in synaptic signaling and behavior Nat Neurosci 6 10 2003 Oct 1072 1078
39. B. Kaltschmidt, and C. Kaltschmidt NF-kappaB in the nervous system Cold Spring Harb Perspect Biol 1 3 2009 Sep a001271
40. B. Kaltschmidt, M. Uherek, H. Wellmann, B. Volk, and C. Kaltschmidt Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis Proc Natl Acad Sci U S A 96 16 1999 Aug 3 9409 9414
41. A. Meunier, A. Latremoliere, E. Dominguez, A. Mauborgne, S. Philippe, and M. Hamon Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat Mol Ther 15 4 2007 Apr 687 697
42. M.P. Mattson, and M.K. Meffert Roles for NF-kappaB in nerve cell survival, plasticity, and disease Cell Death Differ 13 5 2006 May 852 860
43. M. Tamatani, Y.H. Che, H. Matsuzaki, S. Ogawa, H. Okado, and S. Miyake Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons J Biol Chem 274 13 1999 Mar 26 8531 8538
44. P. Kenchappa, A. Yadav, G. Singh, S. Nandana, and K. Banerjee Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases J Neurosci Res 76 4 2004 May 15 466 474
45. G.H. Waetzig, P. Rosenstiel, A. Arlt, A. Till, K. Brautigam, and H. Schafer Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1 FASEB J 19 1 2005 Jan 91 93
46. H. Nawashiro, K. Tasaki, C.A. Ruetzler, and J.M. Hallenbeck TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice J Cereb Blood Flow Metab 17 5 1997 May 483 490
47. A.J. Bruce, W. Boling, M.S. Kindy, J. Peschon, P.J. Kraemer, and M.K. Carpenter Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors Nat Med 2 7 1996 Jul 788 794
48. H.A. Arnett, J. Mason, M. Marino, K. Suzuki, G.K. Matsushima, and J.P. Ting TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination Nat Neurosci 4 11 2001 Nov 1116 1122
49. 2 + accumulation Proc Natl Acad Sci U S A 92 20 1995 Sep 26 9328 9332
50. C. Kaltschmidt, B. Kaltschmidt, H. Neumann, H. Wekerle, and P.A. Baeuerle Constitutive NF-kappa B activity in neurons Mol Cell Biol 14 6 1994 Jun 3981 3992
51. A.A. Pieper, A. Verma, J. Zhang, and S.H. Snyder Poly (ADP-ribose) polymerase, nitric oxide and cell death Trends Pharmacol Sci 20 4 1999 Apr 171 181
52. M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, and J. Bao Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 10 1997 Oct 1089 1095
53. V. Burkart, Z.Q. Wang, J. Radons, B. Heller, Z. Herceg, and L. Stingl Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin Nat Med 5 3 1999 Mar 314 319
54. A.A. Pieper, D.J. Brat, D.K. Krug, C.C. Watkins, A. Gupta, and S. Blackshaw Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes Proc Natl Acad Sci U S A 96 6 1999 Mar 16 3059 3064
55. S.F. Garcia, L. Virag, P. Jagtap, E. Szabo, J.G. Mabley, and L. Liaudet Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation Nat Med 7 1 2001 Jan 108 113
56. O. Ilnytska, V.V. Lyzogubov, M.J. Stevens, V.R. Drel, N. Mashtalir, and P. Pacher Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy Diabetes 55 6 2006 Jun 1686 1694